Annual long term liabilities:
$302.17M-$112.37M(-27.11%)Summary
- As of today (September 7, 2025), CRL annual total long term liabilities is $302.17 million, with the most recent change of -$112.37 million (-27.11%) on December 28, 2024.
- During the last 3 years, CRL annual long term liabilities has fallen by -$180.41 million (-37.38%).
- CRL annual long term liabilities is now -37.38% below its all-time high of $482.58 million, reached on December 25, 2021.
Performance
CRL Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$3.08B-$209.01M(-6.35%)Summary
- As of today (September 7, 2025), CRL quarterly total long term liabilities is $3.08 billion, with the most recent change of -$209.01 million (-6.35%) on June 28, 2025.
- Over the past year, CRL quarterly long term liabilities has dropped by -$147.15 million (-4.56%).
- CRL quarterly long term liabilities is now -18.68% below its all-time high of $3.79 billion, reached on June 25, 2022.
Performance
CRL quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CRL Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.1% | -4.6% |
| 3 y3 years | -37.4% | -18.7% |
| 5 y5 years | -13.7% | +12.7% |
CRL Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.4% | at low | -18.7% | +1.8% |
| 5 y | 5-year | -37.4% | at low | -18.7% | +23.2% |
| alltime | all time | -37.4% | +9051.2% | -18.7% | +1708.5% |
CRL Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $3.08B(-6.4%) |
| Mar 2025 | - | $3.29B(+8.7%) |
| Dec 2024 | $302.17M(-27.1%) | $3.03B(-4.4%) |
| Sep 2024 | - | $3.16B(-2.0%) |
| Jun 2024 | - | $3.23B(-7.6%) |
| Mar 2024 | - | $3.49B(+0.4%) |
| Dec 2023 | $414.54M(+6.2%) | $3.48B(+6.7%) |
| Sep 2023 | - | $3.26B(-5.8%) |
| Jun 2023 | - | $3.46B(-2.7%) |
| Mar 2023 | - | $3.56B(+2.1%) |
| Dec 2022 | $390.40M(-19.1%) | $3.49B(-5.7%) |
| Sep 2022 | - | $3.70B(-2.4%) |
| Jun 2022 | - | $3.79B(+11.1%) |
| Mar 2022 | - | $3.41B(+0.3%) |
| Dec 2021 | $482.58M(+14.3%) | $3.40B(-5.8%) |
| Sep 2021 | - | $3.61B(+5.0%) |
| Jun 2021 | - | $3.44B(+23.2%) |
| Mar 2021 | - | $2.79B(+11.2%) |
| Dec 2020 | $422.25M(+20.6%) | $2.51B(+0.3%) |
| Sep 2020 | - | $2.50B(-8.5%) |
| Jun 2020 | - | $2.73B(-3.5%) |
| Mar 2020 | - | $2.83B(+22.2%) |
| Dec 2019 | $350.22M(+8.5%) | $2.32B(-0.9%) |
| Sep 2019 | - | $2.34B(-7.0%) |
| Jun 2019 | - | $2.51B(+27.1%) |
| Mar 2019 | - | $1.98B(+0.8%) |
| Dec 2018 | $322.76M(+12.0%) | $1.96B(-1.2%) |
| Sep 2018 | - | $1.98B(-7.6%) |
| Jun 2018 | - | $2.15B(+49.6%) |
| Mar 2018 | - | $1.43B(+2.3%) |
| Dec 2017 | $288.30M(+30.6%) | $1.40B(-0.5%) |
| Sep 2017 | - | $1.41B(+3.1%) |
| Jun 2017 | - | $1.37B(-3.7%) |
| Mar 2017 | - | $1.42B(-0.6%) |
| Dec 2016 | $220.73M(+52.0%) | $1.43B(+2.7%) |
| Sep 2016 | - | $1.39B(-6.5%) |
| Jun 2016 | - | $1.49B(+51.7%) |
| Mar 2016 | - | $980.56M(-1.1%) |
| Dec 2015 | $145.18M(+4.7%) | $991.17M(+0.9%) |
| Sep 2015 | - | $982.70M(+12.5%) |
| Jun 2015 | - | $873.58M(-0.7%) |
| Mar 2015 | - | $879.73M(+0.9%) |
| Dec 2014 | $138.72M(+53.1%) | $871.55M(+1.2%) |
| Sep 2014 | - | $860.89M(-3.6%) |
| Jun 2014 | - | $893.19M(+29.0%) |
| Mar 2014 | - | $692.18M(-4.0%) |
| Dec 2013 | $90.58M(-20.4%) | $721.06M(-1.8%) |
| Sep 2013 | - | $734.57M(+0.2%) |
| Jun 2013 | - | $733.35M(+15.8%) |
| Mar 2013 | - | $633.13M(-1.2%) |
| Dec 2012 | $113.76M | $640.90M(-0.2%) |
| Sep 2012 | - | $642.43M(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $653.10M(-15.9%) |
| Mar 2012 | - | $777.02M(-4.6%) |
| Dec 2011 | $110.97M(-3.2%) | $814.16M(-0.7%) |
| Sep 2011 | - | $820.16M(-2.1%) |
| Jun 2011 | - | $837.70M(-4.0%) |
| Mar 2011 | - | $872.48M(+11.2%) |
| Dec 2010 | $114.60M(-6.9%) | $784.87M(-2.5%) |
| Sep 2010 | - | $804.73M(+55.8%) |
| Jun 2010 | - | $516.56M(-7.1%) |
| Mar 2010 | - | $555.97M(-4.2%) |
| Dec 2009 | $123.08M(+3.6%) | $580.50M(-1.3%) |
| Sep 2009 | - | $588.26M(-2.1%) |
| Jun 2009 | - | $601.02M(+1.9%) |
| Mar 2009 | - | $589.68M(-10.6%) |
| Dec 2008 | $118.83M(-22.9%) | $659.47M(+51.2%) |
| Sep 2008 | - | $436.30M(-1.1%) |
| Jun 2008 | - | $441.24M(-29.8%) |
| Mar 2008 | - | $628.39M(-1.7%) |
| Dec 2007 | $154.04M(+5.0%) | $639.04M(-0.1%) |
| Sep 2007 | - | $639.85M(-3.2%) |
| Jun 2007 | - | $661.11M(-2.4%) |
| Mar 2007 | - | $677.47M(-2.4%) |
| Dec 2006 | $146.69M(+136.2%) | $693.78M(+1.0%) |
| Sep 2006 | - | $686.96M(-0.8%) |
| Jun 2006 | - | $692.16M(+74.3%) |
| Mar 2006 | - | $397.10M(+1.8%) |
| Dec 2005 | $62.12M(-67.2%) | $390.07M(-18.0%) |
| Sep 2005 | - | $475.86M(-3.1%) |
| Jun 2005 | - | $490.91M(-36.6%) |
| Mar 2005 | - | $774.48M(-2.6%) |
| Dec 2004 | $189.44M(-10.0%) | $795.42M(+277.4%) |
| Sep 2004 | - | $210.75M(-0.3%) |
| Jun 2004 | - | $211.48M(-0.1%) |
| Mar 2004 | - | $211.72M(+0.6%) |
| Dec 2003 | $210.40M(-0.8%) | $210.40M(-1.3%) |
| Sep 2003 | - | $213.11M(-0.0%) |
| Jun 2003 | - | $213.21M(-0.1%) |
| Mar 2003 | - | $213.44M(+0.7%) |
| Dec 2002 | $212.03M(+24.5%) | $212.03M(+3.1%) |
| Sep 2002 | - | $205.63M(+0.5%) |
| Jun 2002 | - | $204.58M(-25.4%) |
| Mar 2002 | - | $274.15M(+61.0%) |
| Dec 2001 | $170.33M(-21.2%) | $170.33M(-18.0%) |
| Sep 2001 | - | $207.78M(-3.7%) |
| Jun 2001 | - | $215.66M(-12.0%) |
| Mar 2001 | - | $244.98M(+13.4%) |
| Dec 2000 | $216.03M(-47.5%) | $216.03M(-2.6%) |
| Sep 2000 | - | $221.86M(-47.9%) |
| Jun 2000 | - | $426.01M(+2.7%) |
| Mar 2000 | - | $414.70M |
| Dec 1999 | $411.47M(>+9900.0%) | - |
| Dec 1998 | $3.30M | - |
FAQ
- What is Charles River Laboratories International, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. annual long term liabilities year-on-year change?
- What is Charles River Laboratories International, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. quarterly long term liabilities year-on-year change?
What is Charles River Laboratories International, Inc. annual total long term liabilities?
The current annual long term liabilities of CRL is $302.17M
What is the all time high annual long term liabilities for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high annual total long term liabilities is $482.58M
What is Charles River Laboratories International, Inc. annual long term liabilities year-on-year change?
Over the past year, CRL annual total long term liabilities has changed by -$112.37M (-27.11%)
What is Charles River Laboratories International, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of CRL is $3.08B
What is the all time high quarterly long term liabilities for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high quarterly total long term liabilities is $3.79B
What is Charles River Laboratories International, Inc. quarterly long term liabilities year-on-year change?
Over the past year, CRL quarterly total long term liabilities has changed by -$147.15M (-4.56%)